Comparative Analysis of Romosozumab Versus Vertebroplasty With Denosumab: Efficacy, Safety, and Secondary Bone Mineral Density Outcomes
Romosozumab has demonstrated superior pain reduction and lumbar BMD improvement compared to vertebroplasty at 12 months, with no significant differences in radiographic outcomes or adverse events, suggesting it as an alternative to vertebroplasty for OVCF.
Authors
- Seok Woo Kim (ORCID: https://orcid.org/0000-0003-2882-4477)
- Jae Keun Oh (ORCID: https://orcid.org/0000-0001-5127-2661)
- Hyun Woong Mun (ORCID: https://orcid.org/0000-0002-7902-9927)
- Jong Joo Lee (ORCID: https://orcid.org/0000-0003-0905-0330)
- Tae-Hwan Kim (ORCID: https://orcid.org/0000-0002-1658-6961)
- Hyunchul Shin (ORCID: https://orcid.org/0000-0003-3562-0835)
Institutions
- Sacred Heart Hospital (NG)
- Sacred Heart Hospital (US)
- Kangbuk Samsung Hospital (KR)
- Sacred Heart Hospital (US)
- Hallym University Sacred Heart Hospital (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Neurospine
- Published
- 2025-03-31
- DOI
- https://doi.org/10.14245/ns.2449228.614
- Citations
- 5
- Primary Topic
- Spinal Fractures and Fixation Techniques
- Type
- article
- Field-Weighted Citation Impact
- 10.03